HSS Study Highlights Potential for CAR T-Cell Therapy to Transform Lupus Treatment
· newswise.com · popularity 21/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at newswise.com →
Summary
A type of cellular therapy originally developed to treat cancer is showing promise as a potential treatment for people with difficult-to-treat lupus, according to a new study from researchers at Hospital for Special Surgery (HSS). Known as chimeric antigen receptor (CAR) T-cell therapy, the approach is increasingly being investigated for the treatment of systemic lupus erythematosus (SLE). The study, CAR T-Cell Therapy in SLE: A Pooled Analysis, was presented today at the annual meeting of the American College of Rheumatology, ACR Convergence 2026.
Found in: Newswise. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.